Condition
Hidden Hearing Loss
Total Trials
4
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Recruiting4
Clinical Trials (4)
Showing 4 of 4 trials
NCT07646119RecruitingPrimary
Hidden Hearing Loss in Older Adults
NCT07304024Phase 1Recruiting
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
NCT07230236RecruitingPrimary
Relationship Between LS Chirp ABR and Speech-in-Noise Skills in Hidden Hearing Loss
NCT06729632Not ApplicableRecruiting
Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
Showing all 4 trials